Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1986 May;21(5):543-5.
doi: 10.1111/j.1365-2125.1986.tb02840.x.

Captopril and opiate antagonism in essential hypertension

A A Ajayi, P C Rubin, J L Reid
Clinical Trial

Captopril and opiate antagonism in essential hypertension

A A Ajayi et al. Br J Clin Pharmacol. 1986 May.

Abstract

Six patients maintained on 50-100 mg captopril, for 2-25 months, were administered captopril 50 mg orally, together with either naloxone or 0.9% saline vehicle (placebo) given intravenously, in a double-blind crossover study. Naloxone did not appear to modify the circulatory effects of captopril in these patients, in contrast to earlier findings after acute captopril administration in normotensives. The results do not support an important endogenous opioid role in the chronic antihypertensive effect of captopril, but provide evidence that different mechanisms may contribute to the early short term falls in blood pressure, compared to the later long term effects.

PubMed Disclaimer

References

    1. Biochim Biophys Acta. 1970 Aug 21;214(2):374-6 - PubMed
    1. Circ Res. 1971 Oct;29(4):424-31 - PubMed
    1. Eur J Pharmacol. 1979 Oct 26;59(1-2):141-4 - PubMed
    1. Clin Sci (Lond). 1980 Jan;58(1):1-6 - PubMed
    1. Brain Res. 1980 Apr 21;188(1):295-9 - PubMed

Publication types